RE:Poppycock!It's funny, my takeaway from the second last news release where HC granted a CTA-A for the optimization of Phase II so that patients could receive a maintenance treatment was a further positive signal about the safety of the drug/treatment. People here always mentioned the possibility of extra treatments to possibly trigger a response. Dr. Mandel says TLT looks forward to sharing additional safety and efficacy data next month. Maybe we are just not as smart as those guys but they keep claiming to own a stock they don't like.
Rumpl3StiltSkin wrote: There is nothing in the last three press releases that suggest any extra time is needed for BTD/preBTD.
Other than compiling data for this resubmission, which TLT might have done already, I see nothing in either release to suggest that BTD will be delayed significantly. The submission of preBTD approval only takes a few working days, usually. The FDA wanted this data in a certain way and TLT is doing/done that. Everyone needs to relax They have the funds now to get to an AA. :-)